Molecular Characterization of TET2 in Cytogenetically Normal Acute Myeloid Leukemia

被引：0
|
作者：
Lee, J. [1 ,2 ]
Jun, K. [2 ]
Song, S. [2 ]
Oh, S. [1 ]
Shin, J. [1 ]
Kim, H. [1 ]
Lee, J. [1 ,2 ]
机构：
[1] Inje Univ, Busan Paik Hosp, Pusan, South Korea
[2] Haeundae Paik Hosp, Pusan, South Korea
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2013年 / 15卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：858 / 858
页数：1
相关论文
共 50 条
  • [11] TET2 ALTERATIONS IN TAIWANESE CHILDHOOD ACUTE MYELOID LEUKEMIA
    Li, M. J.
    Lin, D. T.
    Tsai, F. J.
    Tsai, C. H.
    Peng, C. T.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S323 - S323
  • [12] CLINICAL IMPLICATION OF TET2 MUTATION WITH NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA IN YOUNGER PATIENTS
    Kim, H. -J.
    Ahn, J. -S.
    Kim, Y. -K.
    Jung, S. -H.
    Yang, D. -H.
    Lee, J. -J.
    Lee, I. -K.
    Kim, N. Y.
    Kim, D. D. H.
    Minden, M. D.
    Jung, C. W.
    Jang, J. -H.
    Kim, H. J.
    Moon, J. H.
    Sohn, S. K.
    Won, J. -H.
    Kim, S. -H.
    Kook, H.
    Kim, N.
    Yoshida, K.
    Ogawa, S.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S118 - S119
  • [13] TET2 Mutation Associated Clonal Hematopoiesis is Linked to a TET2 Polymorphism in Acute Myeloid Leukemia Patients
    Brauer, Dominic
    Grimm, Juliane
    Jentzsch, Madlen
    Bill, Marius
    Goldmann, Karoline
    Schulz, Julia
    Niederwieser, Dietger
    Platzbecker, Uwe
    Schwind, Sebastian
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 108 - 109
  • [14] Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis
    Pastore, Friederike
    Pastore, Alessandro
    Rothenberg-Thurley, Maja
    Metzeler, Klaus H.
    Ksienzyk, Bianka
    Schneider, Stephanie
    Bohlander, Stefan K.
    Braess, Jan
    Sauerland, Maria C.
    Goerlich, Dennis
    Berdel, Wolfgang E.
    Woermann, Bernhard
    Von Bergwelt-Baildon, Michael S.
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    CANCER, 2022, 128 (24) : 4213 - 4222
  • [15] Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia
    Santamaria, Carlos M.
    Chillon, Maria C.
    Garcia-Sanz, Ramon
    Perez, Cristina
    Caballero, Maria D.
    Ramos, Fernando
    Garcia de Coca, Alfonso
    Alonso, Jose M.
    Giraldo, Pilar
    Bernal, Teresa
    Queizan, Jose A.
    Rodriguez, Juan N.
    Fernandez-Abellan, Pascual
    Barez, Abelardo
    Penarrubia, Maria J.
    Balanzategui, Ana
    Vidriales, Maria B.
    Sarasquete, Maria E.
    Alcoceba, Miguel
    Diaz-Mediavilla, Joaquin
    San Miguel, Jesus F.
    Gonzalez, Marcos
    BLOOD, 2009, 114 (01) : 148 - 152
  • [16] Prognostically Important Molecular Markers in Cytogenetically Normal Acute Myeloid Leukemia
    Lin, Tara L.
    Smith, B. Douglas
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 341 (05): : 404 - 408
  • [17] Functional cooperation of CEBPA and TET2 mutations in Acute Myeloid Leukemia
    Heyes, E.
    Schmidt, L.
    Eder, T.
    Volpe, G.
    Chatziathanasiou, K.
    Schmidt, C.
    Frampton, J.
    Grebien, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 40 - 40
  • [18] TET2 GENE MUTATIONS IN CHILDREN SECONDARY ACUTE MYELOID LEUKEMIA
    Takun, Kira
    Lavrinenko, Victoria
    Barovskaya, Julia
    Filipovich, Tatyana
    HLA, 2017, 89 (06) : 476 - 477
  • [19] TET2 expression in a cohort of Egyptian acute myeloid leukemia patients
    Hamed, Nahla A.
    El Halawani, Nabil A.
    Kassem, Heba S.
    Ayad, Mona W.
    Dammag, Enas A.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2015, 40 (04): : 159 - 165
  • [20] Loss of TET2 Creates a Distinct Immunopeptidome in Acute Myeloid Leukemia
    Gu, Xiaorong
    Zhang, Yahan
    Bae, Songa
    Jiang, Dongxu
    Vail, Daniel
    Schlanger, Simon
    Maciejewski, Jaroslaw
    Jha, Babal K.
    BLOOD, 2024, 144 : 4154 - 4155
12345